CAS RN: 875337-44-3

N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide

Product Availability

Choose a grade to view its available package options.

6 package records6 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250529 1ml In stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260222 100mg In stock Shanghai Inquiry
Batchno.20260324 10mg In stock Shanghai Inquiry
Batchno.20260624 25mg In stock Shanghai Inquiry
Batchno.20250419 50mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260403 1mg / 5mg / 25mg Confirm by inquiry Shanghai Inquiry
  • Product code: starshine_CAS875337-44-3
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

875337-44-3 / N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-phenylacetamide

Standard CAS: 875337-44-3 Multi CAS: No

Basic Information

CAS
875337-44-3
Multi CAS
No
Molecular Formula
C26FH20N5O2S2
Molecular Weight
517.600000
Exact Mass
517.104245
InChI
InChI=1S/C26H20FN5O2S2/c1-32-14-20(29-15-32)23-13-19-25(36-23)22(9-10-28-19)34-21-8-7-17(12-18(21)27)30-26(35)31-24(33)11-16-5-3-2-4-6-16/h2-10,12-15H,11H2,1H3,(H2,30,31,33,35)
InChIKey
UFICVEHDQUKCEA-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
36
Aromatic heavy atom count
26
Fraction Csp3
0.08
Rotatable bonds
6
H-bond acceptors
7
H-bond donors
2
Molar refractivity
142.81
TPSA
81.07

LogP / Solubility

WLOGP
5.68
MLOGP
5.04
XLogP3
4.9
Consensus LogP
5.21
Log S (ESOL)
-6.77
Class (ESOL)
Insoluble
Log S (Ali)
-7.91
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.46
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.84

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.56
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
5

Get In Touch

Contact Us